aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded in Germantown, United States, Senseonics Holdings, Inc. is a medical technology company dedicated to revolutionizing diabetes management. The company's core mission is to improve the lives of people with diabetes through innovative glucose monitoring solutions. Senseonics designs, develops, and commercializes continuous glucose monitoring (CGM) systems, with a particular focus on long-term implantable devices. Their flagship product, the Eversense CGM system, offers continuous glucose monitoring for up to 90 days with a single sensor, setting it apart in the market.
Notable figures affiliated with Senseonics include key medical and technological experts who have driven the company's innovations. The company has attracted significant investment from healthcare-focused venture capital firms and strategic partners. Senseonics has achieved several milestones, including FDA approval for its Eversense CGM system and expanding its market presence internationally. The impact of Senseonics' technology is profound, offering a more convenient and reliable glucose monitoring option that enhances the quality of life for individuals with diabetes.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Glucose Monitoring
Technology
Medical Devices
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Senseonics Holdings founded?
Senseonics Holdings was founded in 2015.
Where is Senseonics Holdings's headquarters located?
Senseonics Holdings's headquarters is located in Germantown, MD, US.
How many employees does Senseonics Holdings have?
Senseonics Holdings has 121 employees as of Feb 6, 2024.
Add Comparison
Total Employees Over Time
121
As of Feb 2024
Senseonics Holdings Address
Germantown,
Maryland
20876
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts